SEC Form 4 · accession 0001493152-26-043441
Vivos Therapeutics, Inc. · VVOS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gregg C Johnson
Director
Period of report
Sep 14, 2026
Accepted (ET)
Sep 18, 2026 · 8:17 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001716166
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | holding | — | — | — | 3,997 | I | See footnote |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy)F2 | $0.18 | Sep 14, 2026 | A | 12,000 | A | Sep 14, 2026 | Sep 14, 2036 | Common Stock | 12,000 | 12,000 | D |
Explanation of responses
- F1Shares held by Spite Family Holdings LP, an affiliate of the Reporting Person.
- F2On September 14, 2026 (the "Grant Date"), the Reporting Person received a grant of 12,000 stock options from the Issuer. One-half vested immediately (and the earliest possible exercise date in Table II relates to this tranche), one-fourth will vest on September 30, 2026 and one-fourth will vest on December 31, 2026. The options are exercisable for a period of 10 years from the Grant Date.